Literature DB >> 28785444

Managing Heart Failure Patients with Multivessel Disease - Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention.

John Pepper1.   

Abstract

The foundation of treatment for heart failure with reduced ejection fraction is guideline-directed medical treatment. However, surgical revascularisation offers improved survival and quality of life for patients with more extensive coronary disease and the greatest degree of left ventricular systolic dysfunction and remodelling. The most commonly considered surgical interventions for patients with heart failure with reduced ejection fraction are coronary artery bypass surgery, sometimes combined with surgical ventricular reconstruction and surgery for mitral regurgitation. In this review, the author considers the risks and benefits of coronary artery bypass graft versus percutaneous coronary intervention in the management of heart failure patients with multivessel disease.

Entities:  

Keywords:  Coronary artery bypass graft; heart failure; multivessel disease; percutaneous coronary intervention

Year:  2015        PMID： 28785444      PMCID： PMC5491011          DOI： 10.15420/cfr.2015.1.2.118

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN： 2057-7540


  39 in total

1.  Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy.

Authors:  Jae K Oh; Eric J Velazquez; Lorenzo Menicanti; Gerald M Pohost; Robert O Bonow; Grace Lin; Anne S Hellkamp; Paolo Ferrazzi; Stanislaw Wos; Vivek Rao; Daniel Berman; Andrzej Bochenek; Alexander Cherniavsky; Jan Rogowski; Jean L Rouleau; Kerry L Lee
Journal:  Eur Heart J       Date:  2012-05-14       Impact factor: 29.983

2.  Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina.

Authors: 
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

3.  A standardized definition of ischemic cardiomyopathy for use in clinical research.

Authors:  G Michael Felker; Linda K Shaw; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

4.  Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies.

Authors:  Vijayalakshmi Kunadian; Azfar Zaman; Weiliang Qiu
Journal:  Eur J Heart Fail       Date:  2011-04-08       Impact factor: 15.534

5.  Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation.

Authors:  Edwin C McGee; A Marc Gillinov; Eugene H Blackstone; Jeevanantham Rajeswaran; Gideon Cohen; Farzad Najam; Takahiro Shiota; Joseph F Sabik; Bruce W Lytle; Patrick M McCarthy; Delos M Cosgrove
Journal:  J Thorac Cardiovasc Surg       Date:  2004-12       Impact factor: 5.209

6.  Left ventricular reconstruction: Early and late results.

Authors:  Lynda L Mickleborough; Naeem Merchant; Joan Ivanov; Vivek Rao; Susan Carson
Journal:  J Thorac Cardiovasc Surg       Date:  2004-07       Impact factor: 5.209

7.  Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction.

Authors:  Julio A Panza; Thomas A Holly; Federico M Asch; Lilin She; Patricia A Pellikka; Eric J Velazquez; Kerry L Lee; Salvador Borges-Neto; Pedro S Farsky; Robert H Jones; Daniel S Berman; Robert O Bonow
Journal:  J Am Coll Cardiol       Date:  2013-03-07       Impact factor: 24.094

8.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

Authors:  S Yusuf; D Zucker; P Peduzzi; L D Fisher; T Takaro; J W Kennedy; K Davis; T Killip; E Passamani; R Norris
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321

9.  Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction.

Authors:  Robert E Michler; Jean L Rouleau; Hussein R Al-Khalidi; Robert O Bonow; Patricia A Pellikka; Gerald M Pohost; Thomas A Holly; Jae K Oh; Francois Dagenais; Carmelo Milano; Krzysztof Wrobel; Jan Pirk; Imtiaz S Ali; Robert H Jones; Eric J Velazquez; Kerry L Lee; Marisa Di Donato
Journal:  J Thorac Cardiovasc Surg       Date:  2012-10-27       Impact factor: 5.209

Review 10.  Stunning, hibernation, and assessment of myocardial viability.

Authors:  Paolo G Camici; Sanjay Kumak Prasad; Ornella E Rimoldi
Journal:  Circulation       Date:  2008-01-01       Impact factor: 29.690
View more
  1 in total

1.  Validation of an instrument for perceived factors affecting fruit and vegetable intake based on Pender's health promotion model.

Authors:  Freshteh Khatti-Dizabadi; Jamshid Yazdani-Charati; Reza Amani; Firoozeh Mostafavi
Journal:  J Nutr Sci       Date:  2022-02-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.